GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Conmed Corp (MEX:CNMD) » Definitions » Cyclically Adjusted FCF per Share

Conmed (MEX:CNMD) Cyclically Adjusted FCF per Share : MXN63.32 (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Conmed Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Conmed's adjusted free cash flow per share for the three months ended in Mar. 2025 was MXN24.795. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN63.32 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Conmed's average Cyclically Adjusted FCF Growth Rate was 15.90% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 4.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 3.10% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 4.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Conmed was 9.40% per year. The lowest was -1.80% per year. And the median was 5.20% per year.

As of today (2025-07-01), Conmed's current stock price is MXN1454.00. Conmed's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was MXN63.32. Conmed's Cyclically Adjusted Price-to-FCF of today is 22.96.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Conmed was 70.84. The lowest was 18.48. And the median was 38.61.


Conmed Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Conmed's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conmed Cyclically Adjusted FCF per Share Chart

Conmed Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.83 43.29 38.43 38.02 53.75

Conmed Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.40 43.29 50.74 53.75 63.32

Competitive Comparison of Conmed's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Conmed's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Conmed's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Conmed's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Conmed's Cyclically Adjusted Price-to-FCF falls into.


;
;

Conmed Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Conmed's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=24.795/134.9266*134.9266
=24.795

Current CPI (Mar. 2025) = 134.9266.

Conmed Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 3.675 100.684 4.925
201509 6.039 100.392 8.116
201512 5.346 99.792 7.228
201603 -12.014 100.470 -16.134
201606 8.675 101.688 11.511
201609 15.214 101.861 20.153
201612 6.899 101.863 9.138
201703 8.591 102.862 11.269
201706 8.407 103.349 10.976
201709 6.260 104.136 8.111
201712 11.933 104.011 15.480
201803 13.504 105.290 17.305
201806 11.660 106.317 14.798
201809 -0.070 106.507 -0.089
201812 13.532 105.998 17.225
201903 -5.306 107.251 -6.675
201906 10.865 108.070 13.565
201909 21.027 108.329 26.190
201912 21.865 108.420 27.211
202003 0.707 108.902 0.876
202006 1.445 108.767 1.793
202009 23.903 109.815 29.369
202012 10.477 109.897 12.863
202103 12.531 111.754 15.129
202106 19.183 114.631 22.579
202109 10.099 115.734 11.774
202112 19.134 117.630 21.948
202203 -1.902 121.301 -2.116
202206 8.805 125.017 9.503
202209 12.405 125.227 13.366
202212 -11.048 125.222 -11.904
202303 -4.680 127.348 -4.959
202306 11.940 128.729 12.515
202309 22.390 129.860 23.264
202312 27.770 129.419 28.952
202403 14.375 131.776 14.719
202406 23.391 132.554 23.810
202409 30.242 133.029 30.673
202412 26.306 133.157 26.656
202503 24.795 134.927 24.795

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Conmed  (MEX:CNMD) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Conmed's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=1454.00/63.32
=22.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Conmed was 70.84. The lowest was 18.48. And the median was 38.61.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Conmed Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Conmed's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Conmed Business Description

Traded in Other Exchanges
Address
11311 Concept Boulevard, Largo, FL, USA, 33773
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.